Characterization of CD33 as a new member of the sialoadhesin family of cellular interaction moleculesFREEMAN, S. D; KELM, S; BARBER, E. K et al.Blood. 1995, Vol 85, Num 8, pp 2005-2012, issn 0006-4971Article

Splicing defect of CD33 and inflammatory syndrome associated with occult bacterial infectionBALMER, Maria L; TRÜEB, Beat; LEI ZHUANG et al.Journal of allergy and clinical immunology. 2013, Vol 132, Num 2, pp 490-493, issn 0091-6749, 4 p.Article

Simultaneous engagement of the activatory receptors NKG2D and CD3 for retargeting of effector cells to CD33-positive malignant cellsSTAMOVA, S; CARTELLIERI, M; RIEBER, E. P et al.Leukemia. 2011, Vol 25, Num 6, pp 1053-1056, issn 0887-6924, 4 p.Article

Heteroclitic CD33 peptide with enhanced anti-acute myeloid leukemic immunogenicityBAE, Jooeun; MARTINSON, Jeffrey A; KLINGEMANN, Hans G et al.Clinical cancer research. 2004, Vol 10, Num 20, pp 7043-7052, issn 1078-0432, 10 p.Article

Antibody-Drug Conjugates of Calicheamicin Derivative: Gemtuzumab Ozogamicin and Inotuzumab Ozogamicin : Antibody Conjugates: The Futures Is NowRICART, Alejandro D.Clinical cancer research (Print). 2011, Vol 17, Num 20, pp 6417-6427, issn 1078-0432, 11 p.Article

CD33 is expressed on plasma cells of a significant number of myeloma patients, and may represent a therapeutic targetROBILLARD, N; WUILLEME, S; LODE, L et al.Leukemia. 2005, Vol 19, Num 11, pp 2021-2022, issn 0887-6924, 2 p.Article

Traitement des leucémies aiguës myéloblastiques par les anticorps monoclonaux = Treatment of acute myeloid leukemia with monoclonal antibodiesCASTAIGNE, S; BASTIE, J. N; SUZAN, F et al.Hématologie (Montrouge). 2000, Vol 6, Num AOU, pp 37-40, issn 1264-7527, NSArticle

Differentiation profiles of normal blast cell colonies derived from mononucleated cells, T cell depleted nonadherent cells and CD33-negative, CD34-positive normal human bone marrow cellsHIROTA, Y; JAMAL, N; MESSNER, H. A et al.International journal of cell cloning. 1992, Vol 10, Num 4, pp 241-248, issn 0737-1454Article

Isolation and phenotypic characterization of colonic macrophagesROGLER, G; HAUSMANN, M; VOGL, D et al.Clinical and experimental immunology (Print). 1998, Vol 112, Num 2, pp 205-215, issn 0009-9104Article

CD34⁺/CD33^- cells reselected from macrophage inflammatory protein 1α + interleukin-3-supplemented stroma-nontact cultures are highly enriched for long-term bone marrow culture initiating cellsVERFAILLIE, C. M; MILLER, J. S.Blood. 1994, Vol 84, Num 5, pp 1442-1449, issn 0006-4971Article

Molecular cloning of two isoforms of the murine homolog of the myeloid CD33 antigenTCHILIAN, E. Z; BEVERLEY, P. C. L; YOUNG, B. D et al.Blood. 1994, Vol 83, Num 11, pp 3188-3198, issn 0006-4971Article

Gemtuzumab ozogamicin (Mylotarg) is infrequently associated with sinusoidal obstructive syndrome/veno-occlusive diseaseNABHAN, C; RUNDHAUGEN, L; JATOI, M et al.Annals of oncology. 2004, Vol 15, Num 8, pp 1231-1236, issn 0923-7534, 6 p.Article

Acute myeloid leukemia stem cells and CD33-targeted immunotherapyWALTER, Roland B; APPELBAUM, Frederick R; ESTEY, Elihu H et al.Blood. 2012, Vol 119, Num 26, pp 6198-6208, issn 0006-4971, 11 p.Article

Myeloid antigen, CD13, CD14, and/or CD33 expression is restricted to certain lymphoid neoplasmsNAKASE, K; KITA, K; SHIKU, H et al.American journal of clinical pathology. 1996, Vol 105, Num 6, pp 761-768, issn 0002-9173Article

Haemopoietic progenitor cells are reduced in aplastic anaemiaSCOPES, J; BAGNARA, M; GORDON-SMITH, E. C et al.British journal of haematology. 1994, Vol 86, Num 2, pp 427-430, issn 0007-1048Article

Human bone marrow depleted of CD33-positive cells mediates delayed but durable reconstitution of hematopoiesis : clinical trial of MY9 monoclonal antibody-purged autografts for the treatment of acute myeloid leukemiaROBERTSON, M. J; SOIFFER, R. J; RITZ, J et al.Blood. 1992, Vol 79, Num 9, pp 2229-2236, issn 0006-4971Article

Ontogeny of hematopoietic stem cell development : reciprocal expression of CD33 and a novel molecule by maturing myeloid and erythroid progenitorsBRASHEM-STEIN, C; FLOWERS, D. A; SMITH, F. O et al.Blood. 1993, Vol 82, Num 3, pp 792-799, issn 0006-4971Article

Effects of anti-CD33 blocked ricin immunotoxin on the capacity of CD34⁺ human marrow cells to establish in vitro hematopoiesis in long-term marrow culturesLA RUSSA, V. F; GRIFFIN, J. D; KESSLER, S. W et al.Experimental hematology. 1992, Vol 20, Num 4, pp 442-448, issn 0301-472XArticle

Intérêt du gemtuzumab ozogamicin dans les leucémies aiguës myéloïdes = Gemtuzumab ozogamicin for treatment of acute myeloid leukemiaBROTELLE, Thibault; LEMAL, Richard; MOLUCON-CHABROT, Cécile et al.Bulletin du cancer. 2014, Vol 101, Num 2, pp 211-218, issn 0007-4551, 8 p.Article

Addition of Gemtuzumab Ozogamicin to Induction Chemotherapy Improves Survival in Older Patients With Acute Myeloid LeukemiaBURNETT, Alan K; RUSSELL, Nigel H; WHEATLEY, Keith et al.Journal of clinical oncology. 2012, Vol 30, Num 32, pp 3924-3931, issn 0732-183X, 8 p.Article

Gemtuzumab ozogamicin as postconsolidation therapy does not prevent relapse in children with AML: results from NOPHO-AML 2004HASLE, Henrik; ABRAHAMSSON, Jonas; FORESTIER, Erik et al.Blood. 2012, Vol 120, Num 5, pp 978-984, issn 0006-4971, 7 p.Article

CD33 Detection by Immunohistochemistry in Paraffin-Embedded Tissues : A New Antibody Shows Excellent Specificity and Sensitivity for Cells of Myelomonocytic LineageHOYER, James D; GROGG, Karen L; HANSON, Curtis A et al.American journal of clinical pathology. 2008, Vol 129, Num 2, pp 316-323, issn 0002-9173, 8 p.Article

Fatal hepatic veno-occlusive disease in a phase I study of mylotarg and troxatyl in patients with refractory acute myeloid leukemia or myelodysplastic syndromeGILES, Francis; GARCIA-MANERO, Guillermo; O'BRIEN, Susan et al.Acta haematologica. 2002, Vol 108, Num 3, pp 164-167, issn 0001-5792Article

Pharmacokinetics of gemtuzumab ozogamicin, an antibody-targeted chemotherapy agent for the treatment of patients with acute myeloid leukemia in first relapseDOWELL, James A; KORTH-BRADLEY, Joan; HANJIU LIU et al.Journal of clinical pharmacology. 2001, Vol 41, Num 11, pp 1206-1214, issn 0091-2700Article

Targeted therapy of acute myeloid leukemia with monoclonal antibodies and immunoconjugatesSIEVERS, E. L.Cancer chemotherapy and pharmacology. 2000, Vol 46, pp S18-S22, issn 0344-5704, SUPConference Paper